Search terms
Results 1 - 10 of 151 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 16

Phase I, baseline cohort before the introduction of non-VKA oral anticoagulants (NOACs); Phase II, just after the introduction of the first NOAC dabigatran, with 2-year follow-up in ...

Europace, CLINICAL RESEARCH, Menno V. Huisman, Chang Sheng Ma, Hans-Christoph Diener, Sergio J. Dubner, Jonathan L. Halperin, Kenneth J. Rothman, Christine Teutsch, Nils Schoof, Eva Kleine, Dorothee ...

Date : 01/09/2016 Item size : 261631 bytes

The aim of this study was to assess the effectiveness and safety of dabigatran (direct thrombin inhibitor) vs. acenocoumarol (vitamin K antagonist) in patients with atrial fibrillation (AF) in daily ...

Europace, CLINICAL RESEARCH, Jennie Korenstra, E. Petra J. Wijtvliet, Nic J.G.M. Veeger, Christiane A. Geluk, G. Louis Bartels, Jan L. Posma, Margriet Piersma-Wichers, Isabelle C. Van Gelder, Michiel ...

Date : 01/09/2016 Item size : 247506 bytes

Abstract Aims We aimed to evaluate bleeding risk in clinical practice in patients with atrial fibrillation (AF) being prescribed dabigatran, rivaroxaban, or apixaban compared with warfarin. Using a ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, Cecilie Hoxmark, PÃ¥l Falck, Oddvar Solli, Christian Jonasson

Date : 01/01/2017 Item size : 240628 bytes

In this issue of the journal, Dr Vries and co-workers report data from a study that aimed to explore the level of agreement between windows for different platelet function tests (PFTs) used to ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Stefan Agewall

Date : 01/01/2017 Item size : 132260 bytes

DOACsDirect Oral AnticoagulantsNon-vitamin-K oral anticoagulants NOACs Anticoagulation Coagulation testsIntroduction Unlike vitamin K antagonists (VKAs) such as warfarin that reduce hepatic ...

European Heart Journal - Cardiovascular Pharmacotherapy, Reviews, Tomas Salmonson, Jean-Michel Dogné, Heidi Janssen, Juan Garcia Burgos, Paul Blake

Date : 01/01/2017 Item size : 164607 bytes

Catherine M Otto Correspondence to Professor Catherine M Otto, Division of Cardiology, University of Washington, Seattle, WA 98195, USA; cmotto{at} Stroke prevention is the primary ...

Heart, Heartbeat, Catherine M Otto

Date : 15/01/2017 Item size : 88869 bytes

Atrial fibrillation (AF) is the most common sustained arrhythmia being present in 1.52% of the population and has been found to occur more frequently in oncology patients.1 Cancer and cancer therapy ...

European Heart Journal, CardioPulse, José L Zamorano

Date : 21/09/2016 Item size : 127251 bytes

The Task Force included cardiologists with varying areas of expertise, cardiac surgeons, stroke neurologists, and specialist nurses. Risk factors for atrial fibrillation include age, hypertension, ...

European Heart Journal, Issue @ A Glance, Thomas F. Lüscher

Date : 07/10/2016 Item size : 207219 bytes

Atrial fibrillation (AF) patients with low education miss treatment targets more often Patients with no schooling benefit least from oral anticoagulants, revealed a European Heart Rhythm Association ...

European Heart Journal, CardioPulse

Date : 07/10/2016 Item size : 121322 bytes

ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study) [Anatol J Cardiol] Özcan Baþaran1, Osman Beton2, Volkan Doðan1, ...

Date : 11/01/2017 Item size : 39013 bytes